title: [The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin].
abstract: 6 patients with anaemia associated with myeloma multiplex were treated with human recombinant erythropoietin (rHuEPO, Exprex*) at a dose of 150 units/kg s.c. three times a week for 12 weeks. A good response, defined as an increase of hemoglobin > 20 milligrams above the pretreatment level, was achieved in 4 patients. The erythropoietin serum concentration was measured four times in each patient: twice before commencing and twice after completing the treatment. In patients who responded to rHuEPO therapy the Epo serum concentration decreased whereas in non-responders increased.
authors.affiliation: Kliniki Hematologii, Instytutu Chorób Wewnetrznych Akademii Medycznej w Gdańsku.
authors.forename: H
authors.initials: H
authors.lastname: Ciepłuch
authors.forename: J M
authors.initials: JM
authors.lastname: Zaucha
authors.forename: W
authors.initials: W
authors.lastname: Lysiak-Szydłowska
authors.forename: A
authors.initials: A
authors.lastname: Hellmann
mesh_terms: D000368:Aged; D000740:Anemia / Q000097:blood / Q000628:therapy*; D004921:Erythropoietin / Q000097:blood* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin